Caris Life Sciences Inc. (CAI) experienced a significant 24-hour plunge of 10.28%, with the sharp decline occurring primarily in extended trading sessions following the release of its quarterly earnings report.

The company reported breakeven earnings per share for the quarter ended March 31, beating analyst expectations of a 2-cent loss, while revenue of $216.17 million also exceeded forecasts. However, despite these positive results, investors reacted negatively, driving the stock price down substantially in after-hours trading.

Market sentiment appears to have been influenced by the company's reported quarterly loss of $510 thousand and significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.